Covidien Plc

New U.S. tax rules may lead Medtronic to redo inversion deal

U.S. medical device maker Medtronic Inc is likely to try to renegotiate the structure and terms of its $42.9 billion deal to buy Ireland's Covidien Plc in response to new U.S. tax rules, according to people familiar with the situation.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics